Description

Unifiram Tablets

Unifiram
CAS Number	272786-64-8
Molar Mass	298.33 g/mol
Chemical Formula	C13H15FN2O3S
IUPAC Name	2-(4-fluorophenyl)sulfonyl-1,3,4,7,8,8a-hexahydropyrrolo[1,2-a]pyrazin-6-onee

Introduction

Unifiram, a nootropic compound, stands at the forefront of cognitive enhancement research. Notable for its potent effects on cognitive performance, Unifiram has gained attention in the scientific community for its potential applications in memory enhancement and neuroprotective properties.

Key Characteristics

Unifiram belongs to the racetam family of nootropics and is distinguished by its unique chemical structure and mechanisms of action. It is recognized for its ability to modulate glutamate receptors, promoting synaptic plasticity and neurotransmitter release.

Research Applications

Unifiram has been studied extensively for its potential applications in cognitive research, focusing on memory enhancement, learning abilities, and overall cognitive function. Researchers are exploring its effects on neuroplasticity and synaptic transmission, shedding light on its potential therapeutic applications.

Research Benefits

Unifiram on Increased Cognitive Performance and Anti-Amnesiac Effects

Research indicates that Unifiram may contribute to increased cognitive performance, particularly in tasks related to memory and learning. Studies suggest potential anti-amnesiac effects, making Unifiram a subject of interest for researchers exploring cognitive disorders and age-related cognitive decline.

Unifiram May Prevent Memory Impairment and Loss

Investigations into Unifiram’s impact on memory suggest a potential role in preventing memory impairment and loss. Researchers are exploring its neuroprotective properties, aiming to understand how it may mitigate cognitive decline associated with various conditions.

Summary

Unifiram Tablets, a novel nootropic compound, exhibit promising attributes for cognitive research. With a focus on memory enhancement, cognitive performance, and neuroprotection, Unifiram opens avenues for further exploration in the field of neuroscience. Researchers engaged in cognitive studies may find value in investigating the unique characteristics and potential benefits of Unifiram.

Disclaimer

This content is presented exclusively for educational purposes and should not be construed as medical advice. THE MATERIALS REFERENCED HEREIN ARE EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH USE.

Any clinical research initiatives must be conducted under the guidance of the relevant Institutional Review Board (IRB). Similarly, preclinical research involving animals must comply with the directives of the Institutional Animal Care and Use Committee (IACUC), adhering to the standards delineated by the Animal Welfare Act (AWA).

Our informational content is meticulously designed for research-oriented insights and is not a substitute for individual analysis and verification from credible sources before any purchasing decisions are made.

Upon the finalization of your order and payment, you explicitly acknowledge and agree to adhere to our Terms and Conditions. Customer contentment stands as our paramount concern. Should you find any dissatisfaction with the product received, kindly contact us at 419-707-5450 or email our support team at [email protected].

IMPORTANT NOTICE: All products showcased on our platform are EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH APPLICATIONS. They are expressly not intended for veterinary or human utilization.

References

1. Romanelli MN, Galeotti N, Ghelardini C, Manetti D, Martini E, Gualtieri F. Pharmacological characterization of DM232 (unifiram) and DM235 (sunifiram), new potent cognition enhancers. CNS Drug Rev. 2006 Spring;12(1):39-52. doi: 10.1111/j.1527-3458.2006.00039.x. PMID: 16834757; PMCID: PMC6741768. [Read More].
2. Ghelardini, Carla & Galeotti, Nicoletta & Gualtieri, Fulvio & Manetti, Dina & Bucherelli, Corrado & Baldi, Elisabetta & Bartolini, Alessandro. (2002). The novel nootropic compound DM232 (UNIFIRAM) ameliorates memory impairment in mice and rats. Drug Development Research. 56. 23 – 32. 10.1002/ddr.10055. [Read More].